Shionogi & Co., Ltd. (4507.T)
JPY 2367.0
(1.89%)
JPY 2367.0
(1.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 369.08 Billion JPY | 1.28% |
| 2022 | 364.43 Billion JPY | 30.29% |
| 2021 | 279.72 Billion JPY | 14.33% |
| 2020 | 244.65 Billion JPY | -11.55% |
| 2019 | 276.58 Billion JPY | -10.44% |
| 2018 | 308.84 Billion JPY | 14.07% |
| 2017 | 270.75 Billion JPY | 3.69% |
| 2016 | 261.11 Billion JPY | 11.01% |
| 2015 | 235.21 Billion JPY | 22.63% |
| 2014 | 191.8 Billion JPY | -9.41% |
| 2013 | 211.72 Billion JPY | 3.62% |
| 2012 | 204.32 Billion JPY | 7.81% |
| 2011 | 189.52 Billion JPY | -5.53% |
| 2010 | 200.61 Billion JPY | -0.8% |
| 2009 | 202.23 Billion JPY | 29.16% |
| 2008 | 156.58 Billion JPY | 7.49% |
| 2007 | 145.67 Billion JPY | 10.18% |
| 2006 | 132.21 Billion JPY | 3.55% |
| 2005 | 127.68 Billion JPY | 1.9% |
| 2004 | 125.29 Billion JPY | 3.87% |
| 2003 | 120.62 Billion JPY | -8.5% |
| 2002 | 131.83 Billion JPY | -10.01% |
| 2001 | 146.49 Billion JPY | -1.7% |
| 2000 | 149.03 Billion JPY | 1.33% |
| 1999 | 147.07 Billion JPY | 5.27% |
| 1998 | 139.71 Billion JPY | 3.21% |
| 1997 | 135.37 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 99.61 Billion JPY | 19.82% |
| 2024 Q1 | 83.14 Billion JPY | 1.45% |
| 2023 Q1 | 96.19 Billion JPY | 36.14% |
| 2023 Q3 | 91.76 Billion JPY | -13.81% |
| 2023 Q2 | 106.46 Billion JPY | 10.68% |
| 2023 FY | 369.08 Billion JPY | 1.28% |
| 2023 Q4 | 81.95 Billion JPY | -10.69% |
| 2022 Q2 | 64.51 Billion JPY | 9.55% |
| 2022 FY | 364.43 Billion JPY | 30.29% |
| 2022 Q4 | 70.65 Billion JPY | -58.53% |
| 2022 Q1 | 58.89 Billion JPY | -41.08% |
| 2022 Q3 | 170.36 Billion JPY | 164.06% |
| 2021 Q4 | 99.95 Billion JPY | 62.07% |
| 2021 Q3 | 61.67 Billion JPY | 0.33% |
| 2021 Q2 | 61.46 Billion JPY | 8.53% |
| 2021 FY | 279.72 Billion JPY | 14.33% |
| 2021 Q1 | 56.63 Billion JPY | 0.8% |
| 2020 FY | 244.65 Billion JPY | -11.55% |
| 2020 Q1 | 59.91 Billion JPY | -6.49% |
| 2020 Q2 | 65.68 Billion JPY | 9.63% |
| 2020 Q3 | 62.87 Billion JPY | -4.27% |
| 2020 Q4 | 56.18 Billion JPY | -10.65% |
| 2019 Q1 | 66.49 Billion JPY | -20.83% |
| 2019 Q2 | 67.81 Billion JPY | 1.99% |
| 2019 Q3 | 78.11 Billion JPY | 15.18% |
| 2019 FY | 276.58 Billion JPY | -10.44% |
| 2019 Q4 | 64.06 Billion JPY | -17.98% |
| 2018 Q2 | 66.86 Billion JPY | -12.72% |
| 2018 Q4 | 83.97 Billion JPY | 3.19% |
| 2018 FY | 308.84 Billion JPY | 14.07% |
| 2018 Q1 | 76.61 Billion JPY | 19.49% |
| 2018 Q3 | 81.38 Billion JPY | 21.71% |
| 2017 Q3 | 74.13 Billion JPY | -4.21% |
| 2017 Q2 | 77.39 Billion JPY | 40.45% |
| 2017 Q1 | 55.1 Billion JPY | -14.21% |
| 2017 FY | 270.75 Billion JPY | 3.69% |
| 2017 Q4 | 64.11 Billion JPY | -13.52% |
| 2016 FY | 261.11 Billion JPY | 11.01% |
| 2016 Q2 | 63.04 Billion JPY | 18.19% |
| 2016 Q1 | 53.34 Billion JPY | -17.26% |
| 2016 Q3 | 80.48 Billion JPY | 27.65% |
| 2016 Q4 | 64.23 Billion JPY | -20.19% |
| 2015 FY | 235.21 Billion JPY | 22.63% |
| 2015 Q3 | 68.91 Billion JPY | 23.04% |
| 2015 Q2 | 56.01 Billion JPY | 22.26% |
| 2015 Q1 | 45.81 Billion JPY | -8.93% |
| 2015 Q4 | 64.47 Billion JPY | -6.45% |
| 2014 Q3 | 49.8 Billion JPY | 2.06% |
| 2014 FY | 191.8 Billion JPY | -9.41% |
| 2014 Q2 | 48.79 Billion JPY | 13.74% |
| 2014 Q1 | 42.9 Billion JPY | -15.97% |
| 2014 Q4 | 50.3 Billion JPY | 1.01% |
| 2013 Q4 | 51.05 Billion JPY | -13.76% |
| 2013 FY | 211.72 Billion JPY | 3.62% |
| 2013 Q1 | 48.91 Billion JPY | -7.2% |
| 2013 Q2 | 52.55 Billion JPY | 7.46% |
| 2013 Q3 | 59.19 Billion JPY | 12.63% |
| 2012 Q4 | 52.7 Billion JPY | -3.33% |
| 2012 FY | 204.32 Billion JPY | 7.81% |
| 2012 Q2 | 49.85 Billion JPY | 5.52% |
| 2012 Q1 | 47.25 Billion JPY | -6.25% |
| 2012 Q3 | 54.51 Billion JPY | 9.34% |
| 2011 Q2 | 40.8 Billion JPY | -10.68% |
| 2011 Q4 | 50.4 Billion JPY | -4.26% |
| 2011 Q1 | 45.67 Billion JPY | 3.11% |
| 2011 Q3 | 52.64 Billion JPY | 29.03% |
| 2011 FY | 189.52 Billion JPY | -5.53% |
| 2010 Q2 | 49.93 Billion JPY | -8.17% |
| 2010 Q1 | 54.37 Billion JPY | 2.75% |
| 2010 Q4 | 44.29 Billion JPY | -14.82% |
| 2010 Q3 | 52 Billion JPY | 4.15% |
| 2010 FY | 200.61 Billion JPY | -0.8% |
| 2009 Q4 | 52.91 Billion JPY | -1.17% |
| 2009 Q2 | 48.95 Billion JPY | 4.54% |
| 2009 Q1 | 46.82 Billion JPY | 6.74% |
| 2009 FY | 202.23 Billion JPY | 29.16% |
| 2009 Q3 | 53.54 Billion JPY | 9.38% |
| 2008 Q3 | 40.63 Billion JPY | 10.16% |
| 2008 FY | 156.58 Billion JPY | 7.49% |
| 2008 Q4 | 43.86 Billion JPY | 7.96% |
| 2008 Q2 | 36.88 Billion JPY | 0.0% |
| 2007 FY | 145.67 Billion JPY | 10.18% |
| 2006 FY | 132.21 Billion JPY | 3.55% |
| 2005 FY | 127.68 Billion JPY | 1.9% |
| 2004 FY | 125.29 Billion JPY | 3.87% |
| 2003 FY | 120.62 Billion JPY | -8.5% |
| 2002 FY | 131.83 Billion JPY | -10.01% |
| 2001 FY | 146.49 Billion JPY | -1.7% |
| 2000 FY | 149.03 Billion JPY | 1.33% |
| 1999 FY | 147.07 Billion JPY | 5.27% |
| 1998 FY | 139.71 Billion JPY | 3.21% |
| 1997 FY | 135.37 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -657.068% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 83.108% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | -96.342% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -10323.661% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | -280.434% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -865.638% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 37.061% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -6053.484% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -367.369% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -608.827% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -2630.532% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -4669.785% |
| Tsumura & Co. | 68.81 Billion JPY | -436.33% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -888.42% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -1388.73% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -353.517% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -2134.853% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -635.505% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -618.066% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -34106.302% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -3651.255% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -8267.373% |
| MedRx Co., Ltd | 26 Million JPY | -1419461.538% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -4498.792% |
| Solasia Pharma K.K. | 337 Million JPY | -109421.068% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 50490660.876% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -1103.607% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -579.479% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -977766.681% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | -226.668% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -5458.857% |